433 related articles for article (PubMed ID: 35729567)
21. Identification of Genes with Prognostic Value in the Breast Cancer Microenvironment Using Bioinformatics Analysis.
Ren H; Hu D; Mao Y; Su X
Med Sci Monit; 2020 Apr; 26():e920212. PubMed ID: 32251269
[TBL] [Abstract][Full Text] [Related]
22. Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer.
Liu B; Fan Y; Song Z; Han B; Meng Y; Cao P; Tan K
Int Immunopharmacol; 2020 Dec; 89(Pt B):107078. PubMed ID: 33049497
[TBL] [Abstract][Full Text] [Related]
23. Expression and Clinical Significance of Origin Recognition Complex Subunit 6 in Breast Cancer - A Comprehensive Bioinformatics Analysis.
Chen S; Jin Z; Xin L; Lv L; Zhang X; Gong Y; Liu J
Int J Gen Med; 2021; 14():9733-9745. PubMed ID: 34934348
[TBL] [Abstract][Full Text] [Related]
24. Identification and validation of DHCR7 as a diagnostic biomarker involved in the proliferation and mitochondrial function of breast cancer.
Wang Y; Fan J; Liu Y; Du J; Liang B; Wang H; Song Z
Aging (Albany NY); 2024 Mar; 16(7):5967-5986. PubMed ID: 38526324
[TBL] [Abstract][Full Text] [Related]
25. Lidocaine promotes apoptosis in breast cancer cells by affecting VDAC1 expression.
Long D; Fang X; Yuan P; Cheng L; Li H; Qu L
BMC Anesthesiol; 2022 Aug; 22(1):273. PubMed ID: 36042412
[TBL] [Abstract][Full Text] [Related]
26. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
27. Identification of Breast Cancer Subtypes Based on Endoplasmic Reticulum Stress-Related Genes and Analysis of Prognosis and Immune Microenvironment in Breast Cancer Patients.
Yi C; Yang J; Zhang T; Qin L; Chen D
Technol Cancer Res Treat; 2024; 23():15330338241241484. PubMed ID: 38725284
[No Abstract] [Full Text] [Related]
28. Identification and Verification of Key Tumor Genes Associated with Diagnosis and Prognosis of Breast Cancer Based on Bioinformatics Analysis.
Yu F; Pan XJ; Luo J
Dis Markers; 2022; 2022():9041466. PubMed ID: 35686034
[TBL] [Abstract][Full Text] [Related]
29. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
[TBL] [Abstract][Full Text] [Related]
30. Pan-Cancer Analysis of Voltage-Dependent Anion Channel (VDAC1) as a Cancer Therapeutic Target or Diagnostic Biomarker.
Wang Z; Cheng Y; Song Z; Zhao R
Dis Markers; 2022; 2022():5946110. PubMed ID: 35958281
[TBL] [Abstract][Full Text] [Related]
31. Prognostic and immunological value of
Wang J; Liu Y; Zhang S
Aging (Albany NY); 2021 Jul; 13(13):16904-16921. PubMed ID: 34228637
[TBL] [Abstract][Full Text] [Related]
32. Expression of voltage-dependent anion channels in endometrial cancer and its potential prognostic significance.
Jóźwiak P; Ciesielski P; Forma E; Kozal K; Wójcik-Krowiranda K; Cwonda Ł; Bieńkiewicz A; Bryś M; Krześlak A
Tumour Biol; 2020 Aug; 42(8):1010428320951057. PubMed ID: 32829673
[TBL] [Abstract][Full Text] [Related]
33. DYNLT1 promotes mitochondrial metabolism to fuel breast cancer development by inhibiting ubiquitination degradation of VDAC1.
Huang L; Wei B; Zhao Y; Gong X; Chen L
Mol Med; 2023 Jun; 29(1):72. PubMed ID: 37280526
[TBL] [Abstract][Full Text] [Related]
34. Gene expression meta-analysis identifies VDAC1 as a predictor of poor outcome in early stage non-small cell lung cancer.
Grills C; Jithesh PV; Blayney J; Zhang SD; Fennell DA
PLoS One; 2011 Jan; 6(1):e14635. PubMed ID: 21297950
[TBL] [Abstract][Full Text] [Related]
35. A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study.
Huang Y; Chen L; Tang Z; Min Y; Yu W; Yang G; Zhang L
Front Endocrinol (Lausanne); 2021; 12():774244. PubMed ID: 34867821
[TBL] [Abstract][Full Text] [Related]
36. HSPB8 is a Potential Prognostic Biomarker that Correlates With Immune Cell Infiltration in Bladder Cancer.
Tan Z; Fu S; Huang Y; Duan X; Zuo Y; Zhu X; Wang H; Wang J
Front Genet; 2022; 13():804858. PubMed ID: 35330734
[No Abstract] [Full Text] [Related]
37. NEAT1/MALAT1/XIST/PKD--Hsa-Mir-101-3p--DLGAP5 Axis as a Novel Diagnostic and Prognostic Biomarker Associated With Immune Cell Infiltration in Bladder Cancer.
Rao X; Cao H; Yu Q; Ou X; Deng R; Huang J
Front Genet; 2022; 13():892535. PubMed ID: 35873473
[No Abstract] [Full Text] [Related]
38. Mitochondrial DNA methylation is a predictor of immunotherapy response and prognosis in breast cancer: scRNA-seq and bulk-seq data insights.
Ma Y; Du J; Chen M; Gao N; Wang S; Mi Z; Wei X; Zhao J
Front Immunol; 2023; 14():1219652. PubMed ID: 37457713
[TBL] [Abstract][Full Text] [Related]
39. TIGIT as a Novel Prognostic Marker for Immune Infiltration in Invasive Breast Cancer.
Guo C; Luo Z; Ismtula D; Bi X; Kong H; Wang Y; Yang Z; Mao X
Comb Chem High Throughput Screen; 2023; 26(3):639-651. PubMed ID: 35770416
[TBL] [Abstract][Full Text] [Related]
40. A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer.
Wu X; Lv D; Cai C; Zhao Z; Wang M; Chen W; Liu Y
Front Immunol; 2020; 11():590618. PubMed ID: 33391264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
